Table S3 from PQR309 Is a Novel Dual PI3K/mTOR Inhibitor with Preclinical Antitumor Activity in Lymphomas as a Single Agent and in Combination Therapy
收藏NIAID Data Ecosystem2026-05-17 收录
数据链接：
官方服务：
资源简介：
Baseline gene expression analysis of B cell lymphoma cell lines with higher (IC50 < 200 nM) or lower sensitive (IC50 > 400 nM) to PQR309.
创建时间：
2018-01-01
